The Duke Energy Foundation will fund a program that will allow college students to help energy startups – working with local neighborhoods to bring decarbonization programs to underserved communities in the Carolinas.

The Foundation recently awarded $96,000 to Joules Accelerator – a Charlotte-based nonprofit that helps foster clean energy startups.

“Duke Energy has been a long-time supporter of Joules Accelerator,” said Brian Savoy, Duke Energy’s chief strategy and commercial officer. “This grant will bring students into the program to help energy startups integrate cleantech programs in our local areas.”

The grant will support the creation and deployment of a new program – Joules Camp. Six student interns will work alongside energy startups to provide sustainable energy solutions for communities throughout the Carolinas.

A student intern will work with each pilot effort to improve resiliency and sustainability for a community, provide revenue for small businesses and provide a comprehensive “Joules Camp Story” that showcases how the funding is benefiting the community.

“These are the early days of what we’re now calling Cleantech 2.0,” says Bob Irvin, executive director of Joules Accelerator. “Today, we see an explosion of interest in meeting climate goals through corporate innovation, venture capital investment, university and national laboratory research and national policy initiatives. Our focus is providing early-stage entrepreneurs with the right advisory team to gain market traction in the Carolinas.”

The camp will advance the principles of diversity, equity and inclusion – ensuring that at least one-half of interns are from underrepresented backgrounds, and half the pilot communities are underserved.

Joules Accelerator works to identify, advise, connect and deploy early stage climate startups with the energy network of the Southeast and beyond. Joules moves quickly to make warm connections to relevant stakeholders and to find revenue-generating pilots and other commercialization opportunities for startups. Network members include Duke Energy, Microsoft, S&C Electric, EY, UNCC, the city of Charlotte and more.

Joules presents 12 startups through two cohorts per year. Each cohort lasts 90 days and requires two-four hours per month for meeting with potential customers. The program is free for startups, free to apply and does not take equity.

Yesterday a CMPD officer was shot in the leg while responding to call of a shooting in an occupied dwelling.

According to the official report, the officer was rushed to the hospital with non-life-threatening injuries.

The officer did not return fire and the suspect is still at large.

While on scene, an officer was struck by gunfire in the upper leg and was transported to the hospital with non life threatening injuries. There is no indication at this time officers returned fire.

— CMPD News (@CMPD) June 28, 2022

This now marks the 3rd incident in a week where CMPD officers have faced gunfire during a call for service.

CMPD Chief Johnny Jennings released the following message about yesterday’s incident and the recent rise in officers being shot.

Discovery Channel’s legendary Shark Week is about to fly their massive Shark Week blimps over select cities in promotion of this year’s series.

There will be 2 blimps this year, one flying over select East Coast cities, and a second one flying over select West Coast cities. The East Coast blimp will be taking off on July 1st from Nashville, then will fly over Charlotte and Ocean City, MD on its way up to New York City.

Traveling approximately 250 miles per day, the East Coast blimp measures 128-feet long x 44ft high.

You can follow the blimps progress at Discovery.com/shark-week/blimp

Injectable components, which include devices and containers used for drug delivery, play a vital role in the healthcare sector. With the ever-increasing demand for precision medicine, biologics, and personalized healthcare, the injectable component manufacturing industry is evolving rapidly. Manufacturers are striving to keep up with these changes, adopting new technologies, improving materials, and ensuring the highest standards of safety and efficiency. 

Injectable component manufacturer plays a pivotal role in the development and production of high-quality devices used for drug delivery. These manufacturers are responsible for ensuring that injectable components, such as syringes, vials, cartridges, and autoinjectors, meet rigorous standards for safety, performance, and patient satisfaction. The complexity of biologic drugs and the rise of personalized treatments demand that manufacturers not only produce components that are compatible with these therapies but also ensure that they are easy to use, cost-effective, and compliant with global regulatory standards.

Key Trends Shaping the Future of Injectable Component Manufacturing

1. Rise of Biologics and Biosimilars

Biologics, including monoclonal antibodies, gene therapies, and vaccines, represent a significant portion of new drug development. These complex therapies often require injectable delivery systems due to their nature (e.g., proteins, peptides, and nucleic acids). As biologics continue to gain popularity, the demand for injectable components that can safely and effectively deliver these drugs will increase.

Biosimilars, the follow-on versions of biologics, also require advanced injectable delivery systems. Manufacturers will need to develop components that ensure consistency, stability, and safety across batches of these highly complex drugs. This shift towards biologics and biosimilars will drive innovations in injectable components, such as the development of more sophisticated prefilled syringes, vials, and autoinjectors.

2. Personalized Medicine and Custom Injectable Devices

As personalized medicine continues to emerge, there will be a growing demand for tailored drug delivery solutions. Personalized treatments, which are customized based on a patient’s genetic makeup, disease state, and response to therapy, may require individualized injectable components. These could include specialized syringes, custom drug formulations, or devices with dosage adjustments tailored to each patient’s needs.

The future of injectable component manufacturing will likely see the introduction of smart devices that can monitor patient conditions and adjust drug delivery accordingly. These devices will incorporate features such as connectivity for remote monitoring, automatic dose adjustments, and data collection for better treatment outcomes. This trend will lead to innovations in both drug delivery devices and their integration with digital health technologies.

3. Prefilled Syringes and Autoinjectors: Growing Demand

Prefilled syringes (PFS) and autoinjectors have been gaining popularity due to their convenience and safety. Prefilled syringes are particularly beneficial for patients who need frequent injections, such as those with chronic conditions like rheumatoid arthritis, diabetes, and multiple sclerosis. These devices eliminate the need for manual filling, reducing the risk of contamination and dosing errors.

Autoinjectors, which are designed to allow patients to self-administer injections, are especially important for biologic therapies. As the number of chronic conditions requiring injectable biologics grows, the demand for these self-administration devices will rise. Manufacturers will need to focus on improving the ergonomics, ease of use, and reliability of these devices to ensure patient compliance and reduce the risk of incorrect use.

The future of prefilled syringes and autoinjectors will also involve innovations in the materials used, with manufacturers exploring options like biocompatible plastics and silicone-free components to improve device performance, especially in sensitive drug formulations.

4. Advancements in Materials Science

The materials used in injectable components are constantly evolving. As injectable therapies become more complex, manufacturers are focusing on developing materials that ensure compatibility with biologic and high-risk drugs. For example, glass and plastic components are commonly used in the production of vials, syringes, and cartridges. However, glass can be prone to breakage, while certain plastics may interact with the drug formulation, leading to issues like leaching or degradation.

Future innovations in materials science will likely focus on improving the biocompatibility and stability of injectable components. Manufacturers are exploring the use of new polymeric materials, such as polyethylene terephthalate (PET), which are less likely to react with drugs and can be sterilized more effectively. Additionally, coatings and surface treatments will continue to evolve to enhance drug compatibility and prevent issues like protein aggregation or oxidation.

5. Needle-Free Injection Systems

Needle-free injection systems are poised to become an important trend in injectable component manufacturing. These devices use a high-pressure jet to deliver medications through the skin without the need for needles. This method of drug delivery is especially appealing for patients who have a fear of needles or require frequent injections.

Needle-free devices are already being used for vaccines and some biologic therapies, and their potential to improve patient comfort and compliance is significant. However, these devices face challenges in terms of cost, efficiency, and suitability for different drug types. Future innovations will focus on enhancing the design and functionality of these systems to make them more affordable, reliable, and widely applicable.

6. Integration with Digital Health Technologies

As digital health technologies continue to evolve, there is a growing trend toward integrating injectable components with mobile apps, sensors, and cloud-based platforms. These systems enable real-time monitoring of medication usage, patient adherence, and drug efficacy. Smart syringes and autoinjectors equipped with sensors can track the amount of medication delivered, send notifications to healthcare providers, and ensure that patients follow their prescribed regimen.

The integration of digital health technologies into injectable components will not only improve patient outcomes but also provide valuable data for clinical trials, product development, and post-market surveillance. This trend will drive innovation in both the design of injectable devices and the broader healthcare ecosystem.

7. Sustainability and Eco-Friendly Practices

As sustainability becomes a top priority across industries, injectable component manufacturers are increasingly focusing on reducing their environmental impact. This includes efforts to minimize waste, use recyclable or biodegradable materials, and reduce the carbon footprint of manufacturing processes.

For example, some manufacturers are exploring reusable injectors and packaging solutions that reduce the need for single-use devices and packaging. Additionally, the shift toward green chemistry and environmentally friendly manufacturing techniques will play a key role in the future of injectable component manufacturing.

Innovations to Look Forward To

1. 3D Printing for Custom Injectable Devices

3D printing, or additive manufacturing, has the potential to revolutionize the production of custom injectable devices. Manufacturers can create prototypes quickly and efficiently, leading to faster product development and the ability to design devices tailored to individual patients’ needs. This technology could also allow for the creation of more intricate, patient-specific drug delivery devices with complex features, such as personalized dosing regimens or ergonomic designs.

2. Biodegradable Injectable Components

With an increasing focus on sustainability and reducing plastic waste, biodegradable components are likely to become more common in injectable devices. Materials that break down over time without leaving harmful residues are being researched, and these could be used for syringes, needles, and even packaging.

Conclusion

The future of injectable component manufacturing is marked by rapid innovation and the adoption of new technologies aimed at improving patient outcomes and enhancing drug delivery. From the rise of biologics and personalized medicine to advancements in materials science, digital health integration, and sustainability, injectable component manufacturers must adapt to an ever-changing landscape. As these trends continue to evolve, the industry will witness more efficient, safer, and more patient-friendly drug delivery systems, ultimately contributing to better healthcare worldwide. The future looks promising for injectable component manufacturers, with exciting innovations on the horizon that will shape the way we approach healthcare delivery.